Sponsor or institution
Clinical trials and research at The First Affiliated Hospital of Zhengzhou University
As of November 12, 2026, Find a Trial lists 39 clinical trials run by The First Affiliated Hospital of Zhengzhou University that are recruiting, in China. 1 was first registered in the last 30 days. By phase: Phase 2 (14), Phase 4 (3), Phase 3 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 39Clinical trials
- 1New in 30 days
- 1Country
Newest trials
All recruiting trials (39)
-
PDT plus radioactive biliary stent for unresectable extrahepatic cholangiocarcinoma
This study tests whether combining photodynamic therapy with a self-expandable radioactive stent can help patients with unresectable extrahepatic cholangiocarcinoma stay cancer-free longer and keep their bile ducts open.
-
Hepatic arterial infusion chemotherapy vs capecitabine after surgery for biliary tract cancers
This study tests whether hepatic arterial infusion chemotherapy after surgery helps patients with biliary tract cancers more than capecitabine.
-
How long to fast after esophageal variceal ligation in cirrhosis
This trial tests whether starting oral intake 6 hours after EVL is safer and as effective as waiting 24 or 48 hours in adults with cirrhosis and esophageal varices.
-
A combination therapy for advanced second-line gastric cancer using apatinib with albumin-bound paclitaxel, with or without adebrelimab
This study tests whether adding adebrelimab to a regimen of apatinib and albumin-bound paclitaxel helps patients with advanced gastric or gastroesophageal junction cancer who did not respond to first-line therapy.
-
Ivoximab with Temozolomide for Relapsed Glioma
This trial tests whether adding ivoximab to temozolomide is safe and helps people whose glioma has come back or stopped responding to standard treatment.
-
Tenecteplase for late-window stroke guided by DWI-FLAIR mismatch
This study tests whether giving tenecteplase 4.5–9 hours after stroke onset can improve outcomes for patients with MRI showing DWI-FLAIR mismatch.
-
Drug-coated balloons versus drug-eluting stents for chronic total occlusion of coronary arteries
This will test whether using drug-coated balloons (alone or with a stent when needed) works as well as drug-eluting stents alone for people whose chronically blocked coronary artery has been successfully opened.
-
Azvudine tablets to promote clinical cure in people with chronic hepatitis B.
This trial tests whether azvudine tablets can help achieve clinical cure in adults with chronic hepatitis B who are HBeAg-positive, have high viral load and elevated ALT, and have not received prior antiviral treatment.
-
PD‑1/TGFβ immunotherapy combined with either an EZH2 blocker (SHR2554) or apatinib plus chemotherapy for first‑line advanced stomach cancer
This tests whether adding an EZH2 inhibitor (SHR2554) or the anti‑angiogenic drug apatinib to PD‑1/TGFβ immunotherapy plus CAPOX chemotherapy helps people with unresectable or metastatic stomach or gastroesophageal junction adenocarcinoma starting first‑line treatment.
-
Reducing liver cancer risk in people with chronic hepatitis B — Zhiyuan Project
This project will follow adults with chronic hepatitis B who are receiving common antiviral or pegylated interferon treatments to see if different therapies affect liver cancer risk and other long-term outcomes.
-
Cadonilimab plus cisplatin given before surgery for locally advanced cervical cancer
This study will test whether giving cadonilimab together with cisplatin before surgery helps people with resectable, locally advanced cervical cancer.
-
Neoadjuvant radiochemotherapy with cadonilizumab for locally advanced esophageal squamous cancer
This phase 2 test adds cadonilizumab (a PD‑1/CTLA‑4 bi‑specific antibody) to standard neoadjuvant radiochemotherapy to see if it improves outcomes for people with locally advanced esophageal squamous cell carcinoma who are planned for surgery.
-
Cadonilimab with chemoradiotherapy for oligometastatic Stage IVB cervical cancer
This trial will test whether adding cadonilimab to chemoradiotherapy helps women with oligometastatic Stage IVB cervical cancer.
-
Evaluating neurometabolic networks for predicting survival in colorectal cancer
This study is testing a new way to predict survival in colorectal cancer patients by looking at how different networks in the body interact and affect outcomes.
-
Treatment for liver cancer at high risk of returning
This study is testing a new treatment called AK112 to see if it can help people with liver cancer who are at high risk of their cancer coming back after surgery.
-
Combining Glutathione with Anti-PD-1 and Chemotherapy for Advanced Lung Cancer
This study is testing if adding glutathione to standard chemotherapy and anti-PD-1 treatment can help people with advanced lung cancer feel better and improve their response to treatment after their disease has progressed.
-
Using advanced imaging techniques to improve diagnosis and management of gastric cancer
This study is testing whether advanced imaging techniques can help doctors better diagnose and manage gastric cancer in patients who are about to have surgery.
-
Using Bevacizumab before surgery for high-grade brain gliomas
This study is testing if giving a drug called bevacizumab before surgery can help people with high-grade brain tumors have better outcomes.
-
Combining Nimotuzumab, Sintilimab, and Chemotherapy for Advanced Esophageal Cancer
This study is testing a new combination of two drugs and chemotherapy to see if it helps people with advanced esophageal cancer feel better and live longer.
-
Neoadjuvant treatment for advanced colorectal cancer using Sintilimab
This study tests if giving the immunotherapy drug Sintilimab before surgery can help people with advanced colorectal cancer have better outcomes and lower chances of their cancer coming back.
-
Comparing two conditioning regimens for stem cell transplantation in adult leukemia patients
This study is testing which of two radiation treatments helps adults with leukemia do better after getting a stem cell transplant.
-
Comparing two conditioning regimens for pediatric leukemia treatment
This study is testing which of two treatment plans, Total Body Irradiation or Total Marrow, Central Nervous System and Lymphoid Irradiation, works better for kids with leukemia getting a stem cell transplant to help them feel better and live longer.
-
Comparing two conditioning regimens for pediatric leukemia treatment
This study is testing which of two treatment plans, Total Body Irradiation or Total Marrow Irradiation, works better for kids with leukemia getting a stem cell transplant.
-
Comparing two conditioning regimens for stem cell transplantation in adult leukemia patients
This study is testing which of two treatment methods, Total Body Irradiation or Total Marrow Irradiation, works better for adults with leukemia getting stem cell transplants to kill cancer cells while causing less harm to healthy tissue.
-
Genetically modified T cells for treating malignant tumors
This study is testing a new type of treatment using modified T cells to see if it can help people with different types of cancer feel better and live longer.
-
Using Blinatumomab for treating relapsed Acute B-cell Lymphoblastic Leukemia after transplantation
This study is testing if a new treatment called Blinatumomab can help younger patients with relapsed Acute B-cell Lymphoblastic Leukemia feel better after a stem cell transplant.
-
Methods for treating high gastrin levels in autoimmune gastritis patients
This study is testing different treatments for people with autoimmune gastritis to see if they can help lower high gastrin levels and improve related symptoms.
-
Comparing Urokinase and Alteplase for Treating Acute Ischemic Stroke
This study is testing if a cheaper medication called urokinase works as well and is as safe as the more expensive drug alteplase for treating people with acute ischemic stroke.
-
Combining camrelizumab and apatinib with chemotherapy for advanced esophageal cancer
This study is testing a new combination of two drugs and chemotherapy to see if it helps people with advanced esophageal cancer feel better compared to standard chemotherapy.
-
Using MRD-guided treatment with tislelizumab and chemotherapy for resected NSCLC
This study is testing if a personalized treatment plan using a new drug and chemotherapy can help patients with early-stage non-small cell lung cancer do better after surgery compared to standard treatment.
-
Combining camrelizumab with chemotherapy for esophageal cancer treatment
This study is testing if combining a new immune therapy with chemotherapy can help patients with esophageal cancer feel better and live longer before and after surgery.
-
Using AI to predict molecular pathology in glioma from histopathology images
This study is trying to see if artificial intelligence can help predict the specific types of gliomas using images of the tumors to improve treatment options for patients.
-
Using AI to predict molecular pathology in glioma patients
This study is trying to see if using AI can help predict the specific molecular features of gliomas in patients by looking at their MRI scans and other data to improve treatment options.
-
Using AI to predict survival in glioma patients based on histopathology images
This study is trying to see if using artificial intelligence to analyze tissue images can help doctors predict how long glioma patients might live.
-
Using AI to predict survival in glioma patients
This study is trying to see if using artificial intelligence can help predict how long people with gliomas might live based on their unique tumor details and medical information.
-
Health outcomes of newborns from assisted reproductive technology
This study looks at the health of babies born through assisted reproductive technology to see how it affects their short- and long-term well-being.
-
Investigating health consequences in azoospermia patients
This study looks at the health effects of azoospermia in men to see how it impacts their overall well-being and fertility.
-
Investigating health outcomes in women with Polycystic Ovarian Syndrome
This study looks at the health effects of Polycystic Ovarian Syndrome in women to better understand how it impacts their lives now and in the future.
-
Investigating health consequences in women with primary ovarian insufficiency
This study is trying to learn more about the health effects of premature ovarian insufficiency in women by collecting health information and samples to see how it impacts their lives.
Quick answers
How many clinical trials run by The First Affiliated Hospital of Zhengzhou University are recruiting right now?
39, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 14, Phase 4: 3, Phase 3: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.